Company Filing History:
Years Active: 2016
Title: Kwang-Woo Jung: Innovator in Cryptococcal Research
Introduction
Kwang-Woo Jung is an inventor based in Seoul, South Korea. He is currently associated with Amtixbio Co., Ltd. Despite having no granted patents, he is actively involved in innovative research related to Cryptococcus neoformans. His work focuses on understanding the virulence of this pathogen and developing potential therapeutic strategies.
Latest Patent Applications
Kwang-Woo Jung's notable patent application is titled "Novel Gene Regulating Virulence of Cryptococcus neoformans, and Use Thereof." This invention pertains to a novel gene that regulates the virulence of Cryptococcus neoformans. The application outlines methods for screening anti-Cryptococcal or anti-fungal drug candidate materials effectively. It also discusses a pharmaceutical composition that can enhance the anti-Cryptococcal or anti-fungal effect by modulating the expression of transcription factors. The research includes large-scale virulence tests using insect and animal models to identify transcription factors and analyze their correlation with pathogenicity.
Conclusion
Kwang-Woo Jung is making significant contributions to the field of microbiology through his innovative research on Cryptococcus neoformans. His work has the potential to lead to new therapeutic approaches for combating fungal infections.